Roche Holding Ltd. Share Price Swiss Exchange
Equities
CH0012032048
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CHF | - |
Sales 2024 * | 60.04B 65.24B 5,445B | Sales 2025 * | 63.8B 69.33B 5,787B | Capitalization | 178B 193B 16,147B |
---|---|---|---|---|---|
Net income 2024 * | 13.27B 14.42B 1,203B | Net income 2025 * | 14.75B 16.03B 1,338B | EV / Sales 2024 * | 3.2 x |
Net Debt 2024 * | 14.24B 15.47B 1,292B | Net Debt 2025 * | 8.17B 8.87B 741B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
4.41% | Yield 2025 * |
4.56% | Free-Float | 88.91% |
Latest transcript on Roche Holding Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 01/03/01 | |
Severin Schwan
CHM | Chairman | 57 | 01/08/01 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/15/03 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/96/01 |
1st Jan change | Capi. | |
---|---|---|
+32.85% | 704B | |
+28.59% | 577B | |
-3.77% | 348B | |
+18.33% | 327B | |
+5.49% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-4.01% | 147B | |
-7.40% | 145B |